Concepedia
Statistics
Publications
14
Citations
2.4K
H-Index
Active since
1993
Affiliations
Dana-Farber Cancer Institute(Current)
Harvard University
VA Boston Healthcare System
Dana-Farber/Harvard Cancer Center
Roswell Park Comprehensive Cancer Center
K C Anderson is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and multiple myeloma therapy.
Publications per year
1993–2015
The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.
Teru Hideshima, Paul G. Richardson, D Chauhan et al. · PubMed · 2001 · 1.5K citations
Medicine, Oncology, Pharmacology +17
RETRACTED ARTICLE: SAR650984 directly induces multiple myeloma cell death via lysosomal-associated and apoptotic pathways, which is further enhanced by pomalidomide
Hua Jiang, Chirag Acharya, Gary An et al. · Leukemia · 2015 · 221 citations
Medicine, Oncology, Pharmacology +14
AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3β activation and RNA polymerase II inhibition
Loredana Santo, Sonia Vallet, Teru Hideshima et al. · Oncogene · 2010 · 144 citations · Full text
Medicine, Cancer Biology, Oncology +17
MiR-29b replacement inhibits proteasomes and disrupts aggresome+autophagosome formation to enhance the antimyeloma benefit of bortezomib
Sajjeev Jagannathan, Nikhil Vad, Sivakumar Vallabhapurapu et al. · Leukemia · 2014 · 78 citations · Full text
Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma
David Cervi, Melissa Ooi, Saifun Nahar et al. · Haematologica · 2011 · 73 citations · Full text
1–5 of 14